Table 1

Characteristics of 43 patients with lower respiratory tract infection

*CAP (n=16)*COPD (n=13)CF (n=14)
Median age (years (IQR)†‡78 (69–84)69 (61–81)37 (25–48)
Female, n (%)6 (37.5)5 (38.5)4 (28.6)
Median body mass index (kg/m2) (IQR)26 (24–29)28.3 (23.7–29)21.7 (20.8–26.7)
Median CRP (mg/L) on admission (IQR)†‡43 (15–101)20 (10–151.5)3.5 (2–7)
Diabetes, n (%)3 (18.8)3 (23.1)6 (42.9)
Median blood neutrophil count (108 /L) on admission (IQR)6 (5–10)7.7 (5.2–10.8)5.7 (3.9–9.5)
Duration of chronic infection (years)NANA22.5 (6–38)
  • Data are presented as % (counts), unless otherwise indicated.

  • *Patients with CAP and COPD with enough material and without other lung diseases and antibiotic treatment before enrolment.

  • †P <0.05 CAP vs CF by one-way ANOVA test or Kruskal-Walis test.

  • ‡P <0.05 CF vs COPD by one-way ANOVA test or Kruskal-Walis test.

  • ANOVA, analysis of variance; CAP, community-acquired pneumonia; CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; CRP, C reactive protein; NA, not available.